| Referencias
1. Breza J, Dzurny O, Borowka A. Efficacy and acceptability of Pygeum africanum extract in the treatment of benign prostatic hyperplasia: a multicentre trial in central Europe. Curr Med Res Opin 1998;14(3):127-139.
2. Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr 2000 Dec;3(4A):459-472.
3. Ishani A, MacDonald R, Nelson D, Rutks I. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med 2000 Dec 1;109(8):654-64
4. Paubert-Braquet M, Cave A, Hocquemiller R, Delacroix D, Dupont C, Hedef N, Borgeat P. Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. J Lipid Mediat Cell Signal 1994 May;9(3):285-90
5. Krzeski T, Kazon M, Borkowski A, Witeska A, Kuczera J. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses. Clin Ther 1993 Nov-Dec;15(6):1011-20
6. Chatelain C, Autet W, Brackman F. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension. Urology.1999; 54:473–478.
7. Carani C, Salvioli V, Scuteri A, et al. Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum Africanum at high doses. Arch Ital Urol Nefrol Androl. 1991;63:341–345..
8. Dufour B, Choquenet C, Revol M, Faure G, Jorest R. [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma] Ann Urol (Paris) 1984 May;18(3):193-5
9. Barlet A, Albrecht J, Aubert A, Fischer M, Grof F, Grothuesmann HG, Masson JC, Mazeman E, Mermon R, Reichelt H, et al. Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study] Wien Klin Wochenschr 1990 Nov 23;102(22):667-73
10. Bongi G. Pygeum africanum in the treatment of prostatic adenoma. Anatomo-clinical study. Minerva Urol. 1972;24:129–139.
11. Rizzo M. Terapia medica dell'adenoma della prostata: Valutazione clinica comparativa tra estratto di Pygeum africanum ad alte dosi e placebo. Farmacia Terapia. 1985;2:105–110.
12. Ranno S, Minaldi G, Viscusi G, et al. Efficacy and tolerability of prostate adenoma treatment with Pygeum africanum. Prog Med. 1986;42:165–169.
13. Bassi P, Artibani W, De Luca V, et al. Standardized extract of Pygeum africanum in the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo. Minerva Urol Nefrol. 1987;39:45–50. Levin RM, Das AK. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 2000 Jun;28(3):201-9
14. Menchini-Fabris GF, Giorgi P, Andreini F, et al. New perspectives on the use of Pygeum Africanum in prostato-bladder pathology. Arch Ital Urol Nefrol Androl. 1988;60:313–322.
15. Rhodes L, Primka RL, Berman C, et al. Comparison of finasteride, a 5-alpha reductase inhibitor, and various commercial plant extracts in vitro and in vivo 5-alpha reductase inhibition. Prostate. 1993;22:43–51.
16. Andro MC, Riffaud JP. Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: a review of 25 years of published experience. Curr Ther Res. 1995;56:796–817.
17. Hartmann RW, Mark M, Soldati F. Inhibition of 5 alpha-reductase and aromatase by PHL-00801, a combination of PY 102 (Pygeum africanum) and UR 102 (Urtica dioica) extracts. Phytomedicine. 1996;3:121–128.
|
